Allergan CEO David Pyott Hunting Acquisitions to Fend Off Valeant

Allergan Chief Executive Officer David Pyott said in an interview with the Wall Street Journal he's looking at potential sizable acquisitions as he seeks to fend off a $53 billion hostile takeover offer from Valeant Pharmaceuticals and activist inves

http://www.wgrz.com/video/3668141197001/1/Allergan-CEO-David-Pyott-Hunting-Acquisitions-to-Fend-Off-Valeanthttp://cdn.newslook.com/d6/d6462f4ab6973d74b207011e628391ac/images/frame_ext.jpgAllergan CEO David Pyott Hunting Acquisitions to Fend Off ValeantAllergan Chief Executive Officer David Pyott said in an interview with the Wall Street Journal he's looking at potential sizable acquisitions as he seeks to fend off a $53 billion hostile takeover offer from Valeant Pharmaceuticals and activist invesWall Street JournalValeant PharmaceuticalsFinanceyoutubeYahoo!newslookUnited States of Americadavid pyottallergan00:28